Citation Impact
Citing Papers
Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide
2016
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
2007
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
2023 StandoutNobel
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
2016 Standout
Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
2010
Structure of Dengue Virus
2002 Standout
Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design
2014
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
2016
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Dengue: a continuing global threat
2010 Standout
TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
2018
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice
2020
Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
2010
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
2018 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Coupling of replication and assembly in flaviviruses
2014
Dengue
2012 Standout
Roots and perspectives of contemporary papillomavirus research
1996 StandoutNobel
Production of CCHF virus-like particle by a baculovirus-insect cell expression system
2011
An RNA-centric dissection of host complexes controlling flavivirus infection
2019 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
2011
Defining trained immunity and its role in health and disease
2020 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
2011
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates
2006
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
2019
Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: Advantages for immunization strategies and vaccine implementation
2008
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Human Parvovirus B19
2002 Standout
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
The Human Antibody Response to Dengue Virus Infection
2011
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Immune Response to Dengue Virus and Prospects for a Vaccine
2011
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Genetic Dissection of the Host Tropism of Human-Tropic Pathogens
2015
Works of Iris Valdés being referenced
The Cellular Immune Response Plays an Important Role in Protecting Against Dengue Virus in the Mouse Encephalitis Model
2009
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice
2006
Co-administration of tilapia alpha-helical antimicrobial peptides with subunit antigens boost immunogenicity in mice and tilapia (Oreochromis niloticus)
2013
The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs
2003
Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus
2010
Dengue‐4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
2008
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice
2009
In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus
2009
Expression in Pichia pastoris and Immunological Evaluation of a Truncated Dengue Envelope Protein
2007
Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice
2009
A fragment of the envelope protein from dengue‐1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice
2004
The protein DIIIC‐2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV‐2
2014
Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines
2014
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys
2016